论文部分内容阅读
目的分析羟苯磺酸钙胶囊治疗糖尿病性视网膜病变临床疗效。方法选取从2014年3月~2015年3月收治的60例糖尿病性视网膜病变，随机分为对照组(30)与观察组(30)，对照组采取常规治疗，观察组在对照组基础上给予羟苯磺酸钙胶囊治疗，对比两组临床疗效、不良反应。结果观察组总有效率为86.67%，对照组为63.33%，观察组明显高于对照组(<0.05)。观察组不良反应发生率为6.67%，对照组为26.67%，观察组明显低于对照组(<0.05)。结论对糖尿病性视网膜病变给予羟苯磺酸钙胶囊治疗，效果显著，不良反应少，能改善患者微循环，使得糖尿病性视网膜病变延缓与逆转。“,”Objective To analyze the clinical ef ect of calcium sulfonate capsule in the treatment of diabetic retinopathy. Methods From March 2014~2015 years 3 months from 60 cases of diabetic retinal lesions, were randomly assigned for control group (30) and observation group (30), while the control group was treated with conventional therapy, observation group were treated with calcium dobesilate capsule in the treatment group based on the control, compared two groups of clinical curative ef ect and adverse reaction. Results The total ef ective rate in the observation group was 63.33%, and the control group was 86.67%, the observation group was significantly higher than that in the control group ( <0.05). The incidence of adverse reactions in the observation group was 6.67%, the control group was 26.67%, the observation group was significantly lower than the control group ( <0.05). Conclusion Giving in to diabetic retinopathy calcium dobesilate capsule treatment, obvious ef ect, less adverse reactions, can improve the microcirculation of patients with the diabetic retinopathy delay and reversal.